Lipocalin 2 is required for BCR-ABL-induced tumorigenesis

Xiaohong Leng; Hui‐Kuan Lin; T Ding; Yingjun Wang; Yun Wu; S. Klumpp; Tong Sun; Yi Zhou; Paola Monaco; John W. Belmont; Alan Aderem; Akira Shizuo; Roland K. Strong; Ralph B. Arlinghaus

doi:10.1038/onc.2008.209

Related publications

Article2009

The conditions for determining whether a train-bridge interaction analysis is required

Kai Liu, Guido De Roeck, Geert Lombaert

Article2001

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

Katherine A. Fitzgerald, Eva M. Pålsson‐McDermott, Andrew Bowie, Caroline A. Jefferies, Ashley Mansell, Gareth Brady, Elizabeth Brint, Aisling Dunne, Pearl Gray, Mary T. Harte, Diane McMurray, Dirk E. Smith, John E. Sims, Timothy A. Bird, Luke O'neill

Nature

Letter2017

Reply to: “mRECIST for systemic therapies: More evidence is required before recommendations could be made”

Robert Montal, Riccardo Lencioni, Josep M. Llovet

Journal of Hepatology

Article2006

Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans

Shinobu Saijo, Noriyuki Fujikado, Takahisa Furuta, Soo-Hyun Chung, Hayato Kotaki, Keisuke Seki, Katsuko Sudo, Akira Shizuo, Yoshiyuki Adachi, Naohito Ohno, Takeshi Kinjo, Kiwamu Nakamura, Kazuyoshi Kawakami, Yoichiro Iwakura

Nature Immunology

Article2004

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

Trude H. Flo, Kelly D. Smith, Shintaro Sato, David Rodríguez, Margaret A. Holmes, Roland K. Strong, Akira Shizuo, Alan Aderem